DFX Intelligence
Private Equity Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Equity Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Transactions / S•••••••••
S••••• Acquires S•••••••••
Add-on acquisitionannouncedadd-onannounced Aug 19, 2021Fact
What happened
- Target
- S•••••••••
- Platform
- S•••••add-on basis: S••••• Acquires S••••••••• | S••••• is held by C••••••••• Capital Partners on its portfolio page; published on C••••••••• Capital Partners's own news page
- Control
- Control
- Share acquired
- unknown
- Industry
- healthcare / healthcare, infusion, physician
- Target location
- unknown
- Seller kind
- unknown
- Rollover
- unknown
Values, only where disclosed
- Enterprise value
- Not disclosed
- Purchase price
- Not disclosed
- Equity value
- Not disclosed
- Target revenue
- Not disclosed
- Target EBITDA
- Not disclosed
- Multiple
- Not disclosed
Parties and roles
4 named
Buy side
- ““The S••••••••• acquisition further demonstrates symplr’s ability to execute on its accretive acquisition strategy,” said M••• M••••••, Senior Vice President of C•••••••••.”
- “S••••• Acquires S••••••••• | S••••• is held by C••••••••• Capital Partners on its portfolio page; published on C••••••••• Capital Partners's own news page”
- “S••••• Acquires S••••••••• | S••••• is held by C••••••••• Capital Partners on its portfolio page; published on C••••••••• Capital Partners's own news page”
Side not stated
- “S••••• Acquires S•••••••••”
Evidence
“S••••• Acquires S•••••••••”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 15, 2026